Most people know that using weight loss medication can throw up all sorts of side effects - some more sinister than others - ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Glucagon-like peptide-1 is a hormone that naturally occurs ... diet and exercise have not been sufficient to achieve the needed weight loss or glucose control. Conversely, these injections are not ...

Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete ...

A WOMAN has revealed the bizarre transformation that took place after going on weight loss jabs – and it wasn’t her body. Amy ...

This medication is a glucagon-like peptide-1 (GLP-1 ... Research has shown that semaglutide injections are effective for weight loss in people without diabetes. However, regardless of whether ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...